Document |
Document Title |
WO/2006/056233A1 |
The present invention relates to a process for the preparation of S-carbamoyl cysteine derivatives of formula (I) starting from a cysteine alkyl ester, comprising few steps, which do not include the use of harmful reagents, and allow to ...
|
WO/2006/049264A1 |
There are provided a novel ethylenically unsaturated group-containing isocyanate compound, a process for producing the same, and a reactive monomer produced from the isocyanate compound, a reactive polymer and its use. The ethylenically ...
|
WO/2006/047360A2 |
A novel hydroxyalkyldithiocarbamate borate ester compound is presented according to the formula I: (I) where R=alkyl C1 to C25; R'=H or CO2 R; R'= (CH2)m,OH where m=1 to 8, or alkyl C1 to C25; n=1 to 8. The borate ester compound is prepa...
|
WO/2006/037468A1 |
Compounds of Formula (I) are HIV reverse transcriptase inhibitors, wherein T is O or S; U is O, S, N(R4), or a direct bond linking V to the C(=T) moiety; V is optionally substituted C1-6 alkylene; W is C(O)N(R5) or a direct bond linking ...
|
WO/2006/033728A1 |
Thiocarbonate compounds which, in one embodiment, are utilized as a rheology modifier or associative thickener. The thiocarbonate compounds thicken or increase the viscosity of a composition, preferably an aqueous composition when used i...
|
WO/2006/023691A2 |
Thiocarbonate compounds which, in one embodiment, are utilized as a rheology modifier or associative thickener. The thiocarbonate compounds thicken or increase the viscosity of a composition, preferably an aqueous composition when used i...
|
WO/2006/020116A1 |
Carboxylate terminated thiocarbonates are reacted with a polyfunctional alcohol to form a hydroxyl-terminated thiocarbonate compound.
|
WO/2006/009134A1 |
A novel fungicide that exhibits a wide disease control spectrum against pathogenic fungi acting on various crops and helps resolve worsening resistant strain problems. There are provided diamine derivatives of the formula (1), a process ...
|
WO/2005/102994A1 |
Dithiocarbamate derivative compounds, useful as multifunctional additives for lubricating oils and fuels, are provided and are derived from a reaction product obtained from (a) a di(hydrocarbyl)thiocarbamate intermediate derived from the...
|
WO/2005/090299A2 |
The present invention relates to carbamate derivatives having RNase H, polymerase and/or HIV reverse transcriptase modulatory, and particularly, inhibitory activity. Included in the invention are the carbamate derivatives, compositions c...
|
WO/2005/087718A2 |
The invention relates to thiocarbamides comprising at least one carbodiimide group and at least one thiocarbamide acid ester group of formula (I).
|
WO/2005/080327A1 |
Disclosed are compounds of Formula I, and their N-oxides and suitable salts thereof, which are useful for controlling invertebrate pests. I wherein Q is Q-1 or Q-2; Y is H, F, Cl or CH3; A is CN, C1-C6 alkyl, ORla, SRla, NRlaR2a or CONR1...
|
WO/2005/080326A1 |
A vinyl ester resin is derived from the reaction of an unsaturated acid with an epoxy terminated polymer made from a dithio or a trithio initiator, and optionally from an epoxy resin. The vinyl ester resin can be blended with a miscible ...
|
WO/2005/068419A1 |
The present invention relates to a multifunctional dithiocarboxylate compound. The present invention furthermore relates to a bifunctional dithiocarboxylate compound. The present invention also relates to a monofunctional alkoxycarbonyl ...
|
WO/2005/063018A1 |
Present invention relates to a haloalkene compound of the formula (I)or its salt: wherein each of X1 and X2 is halogen; Y is alkyl, haloalkyl or phenyl; n is 0 to 5; L is -C(=B)Q, -C(=B)B’Q, -C(=B)N(D)Q, -N(D)Q, -N(D)C(=B)Q, -N(D)C(=B)...
|
WO/2005/061448A1 |
The present invention provides methods for treating vascular diseases such an aneurysm (particularly abdominal aortic aneurysm) and neointimal hyperplasia. The methods include use of known compounds such as amiloride and oxamflatin, and ...
|
WO/2005/061443A2 |
The invention relates to benzoyl-substituted phenylalanine amides of formula (I), wherein the variables R1 to R15 have the meanings indicated in the description, the agriculturally useful salts thereof, methods and intermediate products ...
|
WO/2005/025557A1 |
The present invention provides methods and compounds useful in the treatment of conditions such as metastatic cancer spread and atherosclerosis using oxamflatin and derivatives thereof. It has been found that oxamflatin and derivatives t...
|
WO/2005/021488A1 |
An insecticide represented by the following general formula (1). (Symbols in the formula are the same as defined in the description.)
|
WO/2005/020897A2 |
Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Trp-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and characterizing novel small-molecule Trp-p8...
|
WO/2004/108770A1 |
The present invention relates to low odor a-cyano-dithiocarboxylic ester compounds for use as chain transfer agents in free radical polymerizations, and polymerization processes employing them.
|
WO/2004/080938A1 |
A method for preparing S-alkyl and S-aryl thiocarbamates comprising reacting a precursor thiol reagent with trichloroacetyl chloride to produce an S-alkyl and S-aryl trichloroacetyl thioester intermediate, which is reacted with an amine ...
|
WO/2004/067505A2 |
The present invention relates to bismuth dithiocarbamate compounds of general formula I: wherein R and R1 are the same or different, and each is an alkyl, substituted alkyl, aryl or a substituted aryl; X is a halide or a pseudo-halide; a...
|
WO/2004/058174A2 |
This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in p...
|
WO/2004/043910A2 |
This invention generally relates to a new tungsten dithiocarbamate compound and a process for making the same by the reaction of divalent metal tungstates with dithiocarbamates in an alkaline sodium sulfide and/or sodium hydrogen sulfide...
|
WO/2004/037780A1 |
Dithiocarbonate derivatives are disclosed, along with a process for preparing the same. The dithiocarbonate compounds can be utilized as initators, chain transfer agents and/or terminators in controlled free radical polymerizations. The ...
|
WO2003027064B1 |
The present invention is related to new vanilloid analogues containing resiniferatoxin pharmacophores, pharmaceutical compositions comprising such analogues, and their uses as vanilloid receptor agonistsand potent analgesics.The present ...
|
WO/2003/104178A1 |
Where Y, R¿1?-R¿8? and R¿101?-R¿108? are as defined in the specification. Compounds of formula (II) and methods of inhibiting the cytokine or biological activity of Macrophage Migrating Inhibitory Factor (MIF) comprising contacting M...
|
WO/2003/104203A1 |
Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) as defined herein, is provided. The invention also relates to methods of t...
|
WO/2003/099784A1 |
In accordance with the present invention, there are provided methods for producing pharmaceutical-grade dithiocarbamates and disulfide derivatives thereof. Invention methods are preferably conducted under sterile conditions, thereby prod...
|
WO/2003/078390A1 |
A novel phenolic compound; and a recording material containing the compound and having excellent storage stability. The phenolic compound is represented by the formula (I): (I) wherein m is an integer of 0 to 2; R1 and R2 each independen...
|
WO/2003/059896A1 |
The invention relates to a method for producing compounds of formula (I), wherein R represents H or F. Said method is characterised in that a compound of formula (II), wherein X represents halogen, mesylate or tosylate, is reacted with a...
|
WO/2003/059873A1 |
This invention relates to novel compounds characterized by the general Formula (I) any of its enantiomers or any mixture of its enantiomers, or a pharmaceutically acceptable salt thereof, or an N-oxide thereof, useful as potassium channe...
|
WO/2003/057169A2 |
The present invention pertains, at least in part, to novel substituted 4-dedimethylamino tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infect...
|
WO/2003/053337A2 |
A method is provided for the preparation of compounds of the formula (R1)(R2)NC(=X)S(O)nR3 or (R1)(R2)NC(=X)OS(O)nR3, wherein R1, R2 and R3, X and n have any of the meanings defined in the specification. A method is also provided for the...
|
WO/2003/044031A1 |
The invention relates to a technetium or rhenium complex of formula (I): [M(R1CS3)2L] (I)in which M is Tc or Re, R1 represents an alkyl, cycloalkyl, aralkyl or aryl group which is unsubstituted or substituted by one or more substituents ...
|
WO/2003/042153A1 |
A pest control agent which is highly effective in pest control and is highly safe for crops, natural enemies to pests, and mammals. It is a difluoroalkene derivative represented by the following general formula [1] or a pharmacologically...
|
WO/2003/034989A2 |
Acylated $g(a)-hydroxyarylbutanamines and related sulfonamides, ureas and carbamates that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds. The compounds have the formu...
|
WO/2003/014062A1 |
Certain thiol and acylthiol compounds inhibit retrovirus growth by attacking the highly conserved zinc finger regions of essential viral proteins. These compounds, compositions containing them, and methods of using them to treat retrovir...
|
WO/2003/014292A2 |
The invention discloses a novel combinatorial library comprising a plurality of bifunctional molecules having the formula CF - PF wherein CF is a moiety of a specific chemical or biological activity and PF is a second moiety imparting th...
|
WO/2003/008428A1 |
Organo-Imino molybdenum complexes are disclosed having the formula Z¿2?N¿2?MOS¿4?C¿2?N¿2?R¿4? wherein Z and R are independently selected from the group consisting of linear hydrocarbon groups, branched hydrocarbon groups, cyclic hy...
|
WO/2002/096884A2 |
The invention relates to novel substituted benzoylketones of formula (I), in which Q = O (oxygen) or S (sulphur), R?1¿ - R?5¿ and Z have the meaning given in the description and several methods for production thereof and use thereof as...
|
WO/2002/092574A1 |
The invention relates to novel substituted benzoylcyclohexenones of formula (I), in which Q, R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, Y and Z are defined as per the description. The invention also relates to a method for their production and t...
|
WO/2002/059074A1 |
A compound represented by the general formula (I) (wherein R?1¿ represents C¿1-6? alkyl, etc.; R?2¿ and R?3¿ are the same or different and each represents hydrogen, etc.; R?a¿ represents C¿1-6? alkyl, etc.; Arom represents aryl, et...
|
WO/2002/044175A2 |
The present invention provides a compound for chelating a metal or a metal complex, characterized in that it consists of a bis-dithiocarbamate structure (F) having the formula below: (formule chimique ô insérer ici)in which n and m are...
|
WO/2002/044126A2 |
The present invention relates to novel, non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilin proteins. In the compounds of this invention, at least two carbo-or heterocyclic groups are attached ...
|
WO/2002/034835A1 |
Provided is a vulcanising agent for vulcanising bitumen, which vulcanising agent comprises a sulphur agent and a binder, wherein the vulcanising agent is in the form of pellets. Further provided is a process for producing a surfacing com...
|
WO/2002/026704A1 |
The invention relates to the use of cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and carbamoyloxy as therapeutic agents e.g. as ocular hypotensives. The compounds used in accordance with the invention are represented by formula (...
|
WO/2002/026225A1 |
In accordance with the present invention, there are provided methods for the in vivo reduction of free radical levels in nammalian subjects in need thereof. In contrast to the inhibitory approach described in the prior art (i.e., wherein...
|
WO/2002/016317A1 |
The present invention relates to an antagonist against vanilloid receptor and the pharmaceutical compositions containing the same.As diseases associated with the activity of vanilloid receptor, pain, acute pain, chronic pain, neuropathic...
|